Dashboard
Manage Tickers

AMPAMERIPRISE FINANCIAL INC

NYSE ameriprise.com


$ 429.59 $ -1.80 (-0.42 %)    

Wednesday, 31-Jul-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.02 $ 7.98 (1.72 %)
DIA $ 408.46 $ 1.05 (0.26 %)
SPY $ 551.56 $ 3.52 (0.64 %)
TLT $ 94.83 $ 0.98 (1.04 %)
GLD $ 226.56 $ 4.04 (1.82 %)
$ 430.07
$ 434.36
$ 429.39 x 100
-- x --
$ 429.42 - $ 436.13
$ 303.24 - $ 449.94
352,636
na
42.72B
$ 1.46
$ 13.65
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 05-02-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-05-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 08-03-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 11-03-2014 09-30-2014 10-Q
40 08-04-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Ameriprise Financial Services Files Lawsui...
07/30/2024 16:49:20

Ameriprise Financial Services, LLC today filed a lawsuit in United States District Court contending that defendant LPL Financia...

rbc-capital-maintains-outperform-on-ameriprise-finl-raises-price-target-to-500
RBC Capital Maintains Outperform on Amerip...
07/30/2024 13:33:29

RBC Capital analyst Kenneth Lee maintains Ameriprise Finl (NYSE:AMP) with a Outperform and raises the price target from $487...

keefe-bruyette--woods-maintains-market-perform-on-ameriprise-finl-lowers-price-target-to-460
Keefe, Bruyette & Woods Maintains Market P...
07/30/2024 12:45:47

Keefe, Bruyette & Woods analyst Ryan Krueger maintains Ameriprise Finl (NYSE:AMP) with a Market Perform and lowers the p...

unveiling-6-analyst-insights-on-ameriprise-finl
Unveiling 6 Analyst Insights On Ameriprise...
07/29/2024 18:00:25

morgan-stanley-maintains-equal-weight-on-ameriprise-finl-lowers-price-target-to-440
Morgan Stanley Maintains Equal-Weight on A...
07/29/2024 16:31:58

Morgan Stanley analyst Michael Cyprys maintains Ameriprise Finl (NYSE:AMP) with a Equal-Weight and lowers the price target f...

ameriprise-finl-q2-2024-adj-eps-872-beats-853-estimate
Ameriprise Finl Q2 2024 Adj EPS $8.72 Beat...
07/24/2024 20:11:57

Ameriprise Finl (NYSE:AMP) reported quarterly earnings of $8.72 per share which beat the analyst consensus estimate of $8.53 by...

heres-how-much-you-would-have-made-owning-ameriprise-finl-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
07/18/2024 20:00:23

ubs-maintains-buy-on-ameriprise-finl-lowers-price-target-to-495
UBS Maintains Buy on Ameriprise Finl, Lowe...
07/09/2024 20:29:56

UBS analyst Brennan Hawken maintains Ameriprise Finl (NYSE:AMP) with a Buy and lowers the price target from $500 to $495.

keefe-bruyette--woods-maintains-market-perform-on-ameriprise-finl-raises-price-target-to-470
Keefe, Bruyette & Woods Maintains Market P...
07/08/2024 11:41:02

Keefe, Bruyette & Woods analyst Ryan Krueger maintains Ameriprise Finl (NYSE:AMP) with a Market Perform and raises the p...

heres-how-much-you-would-have-made-owning-ameriprise-finl-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
07/05/2024 18:00:24

jefferies-maintains-buy-on-ameriprise-finl-raises-price-target-to-504
Jefferies Maintains Buy on Ameriprise Finl...
06/28/2024 16:34:12

Jefferies analyst Suneet Kamath maintains Ameriprise Finl (NYSE:AMP) with a Buy and raises the price target from $500 to $504.

peeling-back-the-layers-exploring-ameriprise-finl-through-analyst-insights
Peeling Back The Layers: Exploring Ameripr...
06/28/2024 15:01:13

piper-sandler-maintains-underweight-on-ameriprise-finl-lowers-price-target-to-387
Piper Sandler Maintains Underweight on Ame...
06/28/2024 13:17:43

Piper Sandler analyst John Barnidge maintains Ameriprise Finl (NYSE:AMP) with a Underweight and lowers the price target from...

looking-into-ameriprise-finls-recent-short-interest
Looking Into Ameriprise Finl's Recent Shor...
06/12/2024 19:45:19

heres-how-much-1000-invested-in-ameriprise-finl-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Ameripri...
06/04/2024 21:00:22

1000-invested-in-ameriprise-finl-15-years-ago-would-be-worth-this-much-today
$1000 Invested In Ameriprise Finl 15 Years...
05/17/2024 17:00:22

how-is-the-market-feeling-about-ameriprise-finl
How Is The Market Feeling About Ameriprise...
05/15/2024 16:00:15

in-depth-examination-of-7-analyst-recommendations-for-ameriprise-finl
In-Depth Examination Of 7 Analyst Recommen...
05/06/2024 17:00:16

argus-research-maintains-buy-on-ameriprise-finl-raises-price-target-to-460
Argus Research Maintains Buy on Ameriprise...
05/06/2024 15:46:32

Argus Research analyst Kevin Heal maintains Ameriprise Finl (NYSE:AMP) with a Buy and raises the price target from $440 to $...

heres-how-much-you-would-have-made-owning-ameriprise-finl-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
05/02/2024 15:00:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)